PENTREXCILINA
- Product NDC
- 69517-155
- Requested package NDC
- 69517-155-72
- 11-digit product format
- 695170155
- Labeler code
- 69517
- Product ID
- 69517-155_083396b6-6a36-ffc7-e063-6294a90ad8e2
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Healthlife of USA
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-01-05
- Substance
- ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
- Active strength
- 325; 5; 15 mg/1; mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 69517-155 | 69517-155-72 | I | Inactivated by FDA | excluded / ndc_excluded.zip | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 69517-155 | 69517-155-72 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 9bebd1f3094a… | 5416666fcb17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PENTREXCILINA
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 325 mg/1 |
| PHENYLEPHRINE HYDROCHLORIDE | 5 mg/1 |
| DEXTROMETHORPHAN HYDROBROMIDE | 15 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| 04JA59TNSJ | Internal UNII lookup |
| 9D2RTI9KYH | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1367205 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| ae9ada14-0ec8-4c01-a874-237f2108936a | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e4e263da-1c53-440f-bb80-b7a575843b5a | Product name | 1 | 20260313 |
| d2168cac-a261-415a-9c78-3522859fa720 | Product name | 3 | 20251124 |
| 05a8cdd1-eeb8-409e-b938-0778225eca7d | Product name | 4 | 20250221 |
| e5b5c132-b15d-435b-9faa-2f74e5cadcf9 | Product name | 8 | 20250220 |
| f489e8f3-5c9e-4818-b539-a73587edcfc7 | Product name | 2 | 20240229 |
| 0f7ae452-206d-4fc4-868d-56fc47074084 | Product name | 1 | 20231011 |
| b5abe2e3-39a1-43eb-9bff-f3c1653fe3df | Product name | 2 | 20190930 |
| e0b6c8be-f2bd-9f86-a9fc-3ed56ffaa814 | Product name | 3 | 20150910 |
| 42f3c020-f1b3-89bc-7bdc-e1f10e680485 | Product name | 1 | 20140508 |
| e949165d-714d-e548-2b76-0cb5def16f30 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 69517-155-06 | 2023-02-23 | PENTREXCILINA |
| 69517-155-72 | 2023-02-23 | PENTREXCILINA |
| 69517-155-06 | 2023-01-30 | PENTREXCILINA |
| 69517-155-72 | 2023-01-30 | PENTREXCILINA |
| 69517-155-06 | 2021-12-03 | PENTREXCILINA |
| 69517-155-72 | 2021-12-03 | PENTREXCILINA |
| 69517-155-06 | 2020-01-31 | PENTREXCILINA |
| 69517-155-72 | 2020-01-31 | PENTREXCILINA |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69517-155-06 | PENTREXCILINA | 2 in 1 POUCH | TABLET | 2 | 8 | |
| 69517-155-06 | PENTREXCILINA | 6 in 1 PACKAGE | TABLET | 6 | 8 | |
| 69517-155-72 | PENTREXCILINA | 2 in 1 POUCH | TABLET | 2 | 8 | |
| 69517-155-72 | PENTREXCILINA | 72 in 1 PACKAGE | TABLET | 72 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69517-155 | PENTREXCILINA (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE) TABLET [HEALTHLIFE OF USA] | 8 | Current NDC, Legacy NDC, 4 package rows | 20231021_ae9ada14-0ec8-4c01-a874-237f2108936a.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Family Wellness Oxymetazoline No Drip | OXYMETAZOLINE | FAMILY DOLLAR (Family Wellness) | 0c006b1c-8ab2-4b9c-8738-e7001c1bb47d | 2026-10-26 | Warnings | M012 |
| Family Wellness Oxymetazoline Sinus Severe | OXYMETAZOLINE | FAMILY DOLLAR (Family Wellness) | 13237d31-c60a-49f8-9b96-4414cf766a08 | 2026-10-26 | Warnings | M012 |
| HISTEX-DM New Formulation | DEXTROMETHORPHAN HBR, PSEUDOEPHEDRINE HCI, AND TRIPROLIDINE HCI | Allegis Pharmaceuticals, LLC | 30010401-e5b4-2bd9-e063-6394a90a0b0b | 2026-10-26 | Warnings | M012 |
| HISTEX-DM | DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, AND TRIPROLIDINE HYDROCHLORIDE | Allegis Pharmaceuticals, LLC | 836d062c-29f0-4fd7-b65c-771a3bbd52c4 | 2026-10-26 | Warnings | M012 |
| HISTEX | TRIPROLIDINE HYDROCHLORIDE | Allegis Pharmaceuticals, LLC | cc466d33-cf3e-4f1c-a794-6d3d79903adf | 2026-10-26 | Warnings | M012 |
| HISTEX PD Drops New Formulation | TRIPROLIDINE HYDROCHLORIDE | Allegis Pharmaceuticals, LLC | 0c693f15-5d76-3dbf-e063-6294a90af9ac | 2026-10-26 | Warnings | M012 |
| Guaifenesin 400mg | GUAIFENESIN | Marlex Pharmaceuticals Inc | 13f4db4e-687e-9d7b-e063-6294a90ab088 | 2026-10-26 | Warnings | M012 |
| Guaifenesin 200mg | GUAIFENESIN | Marlex Pharmaceuticals Inc | 13b8f480-d1ac-d70c-e063-6394a90ab4f4 | 2026-10-26 | Warnings | M012 |
| NASAL and SINUS DECONGESTANT | PHENYLEPHRINE HYDROCHLORIDE | JHK Inc dba American Safety & First Aid | 63e51305-2575-49c4-9fda-7b3e1b4b6ede | 2026-10-26 | Warnings | M012 |
| MUCINEX FAST-MAX NIGHTTIME COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, TRIPROLIDINE HYDROCHLORIDE | Reckitt Benckiser LLC | 3a24b06c-00a6-c2ef-e063-6294a90a4d72 | 2026-10-25 | Warnings | M012 |
| Mucinex Nightshift Cold and Flu Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND TRIPROLIDINE HYDROCHLORIDE | Reckitt Benckiser LLC | 316b5569-b66f-f30c-e063-6394a90ae147 | 2026-10-25 | Warnings | M012 |
| Mucinex Fast-Max Kickstart Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | fda745ca-b486-47ca-e053-6394a90a87c3 | 2026-10-24 | Warnings | M012 |
| Mucinex Fast-Max Kickstart Severe Congestion and Cough and Mucinex Fast-Max Nighttime Cold and Flu | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, ACETAMINOPHEN,TRIPROLIDINE HYDROCHLORIDE | Reckitt Benckiser LLC | 34fd2458-9acd-cdf7-e063-6394a90a3d0a | 2026-10-24 | Warnings | M012 |
| DAYTIME NIGHTTIME COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Amazon.com Services LLC | e1b2d448-f84f-49ec-821c-ad03c4c6a59a | 2026-10-23 | Warnings | M012 |
| Mucinex Fast-Max Kickstart Severe Congestion and Cough Maximum Strength | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Reckitt Benckiser LLC | 19105007-0193-0764-e063-6294a90a01a4 | 2026-10-23 | Warnings | M012 |
| Publix Maximum Strength | OXYMETAZOLINE HYDROCHLORIDE | PUBLIX SUPER MARKETS, INC | cf49a06d-f095-48bf-bcd2-a410066ff9af | 2026-10-22 | Warnings | M012 |
| Publix | OXYMETAZOLINE HYDROCHLORIDE | PUBLIX SUPER MARKETS, INC | 283e42b9-173c-4deb-9377-ff649efc177f | 2026-10-22 | Warnings | M012 |
| CHILDRENS ALLERGY RELIEF | DIPHENHYDRAMINE HCL | Amazon.com Services LLC | c10709ea-7c49-44f6-abde-330c09ee960b | 2026-10-22 | Warnings | M012 |
| Mucus Relief DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | Chain Drug Marketing Association, Inc. | d02f32c1-716e-4753-abba-ff97c4dc9e22 | 2026-10-22 | Warnings | M012 |
| Tylenol Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Kenvue Brands LLC | 7a60184f-91a9-4b85-b243-871deca63450 | 2026-10-22 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1367205 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Tablet | PSN | ae9ada14-0ec8-4c01-a874-237f2108936a | 8 |
| 1367205 | acetaminophen 325 MG / dextromethorphan hydrobromide 15 MG / phenylephrine hydrochloride 5 MG Oral Tablet | SCD | ae9ada14-0ec8-4c01-a874-237f2108936a | 8 |
| 1367205 | APAP 325 MG / dextromethorphan hydrobromide 15 MG / phenylephrine hydrochloride 5 MG Oral Tablet | SY | ae9ada14-0ec8-4c01-a874-237f2108936a | 8 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 69517-155-72 | 69517015572 | 72 POUCH in 1 PACKAGE (69517-155-72) / 2 TABLET in 1 POUCH | 72 pouch | 2018-01-05 | 0000-00-00 | No | No | Current |